The peptides, which are increasingly marketed as providing longevity and health benefits, were removed in 2023 from the ...

The U.S. FDA appears poised to allow compounding pharmacies to again sell injectable peptides, a class of products with ...

In early 2024, the American Society of Health-System Pharmacists (ASHP) reported a record 323 active drug shortages, many affecting sterile injectable medications. This situation was exacerbated later ...